| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. KL Kotloff, JP Winickoff, B Ivanoff, JD Clemens, DL Swerdlow, ... Bulletin of the World Health Organization 77 (8), 651, 1999 | 1792 | 1999 |
| Vaccination greatly reduces disease, disability, death and inequity worldwide FE Andre, R Booy, HL Bock, J Clemens, SK Datta, TJ John, BW Lee, ... Bulletin of the World health organization 86, 140-146, 2008 | 1474 | 2008 |
| The protective efficacy of polyvalent pneumococcal polysaccharide vaccine ED Shapiro, AT Berg, R Austrian, D Schroeder, V Parcells, A Margolis, ... New England Journal of Medicine 325 (21), 1453-1460, 1991 | 1378 | 1991 |
| A study of typhoid fever in five Asian countries: disease burden and implications for controls RL Ochiai, CJ Acosta, MC Danovaro-Holliday, D Baiqing, ... Bulletin of the world health organization 86 (4), 260-268, 2008 | 902 | 2008 |
| Trial of calcium to prevent preeclampsia RJ Levine, JC Hauth, LB Curet, BM Sibai, PM Catalano, CD Morris, ... New England Journal of Medicine 337 (2), 69-77, 1997 | 871 | 1997 |
| Evidence for several waves of global transmission in the seventh cholera pandemic A Mutreja, DW Kim, NR Thomson, TR Connor, JH Lee, S Kariuki, ... Nature 477 (7365), 462-465, 2011 | 797 | 2011 |
| Looking beyond COVID-19 vaccine phase 3 trials JH Kim, F Marks, JD Clemens Nature medicine 27 (2), 205-211, 2021 | 703 | 2021 |
| The global burden of cholera M Ali, AL Lopez, YA You, YE Kim, B Sah, B Maskery, J Clemens Bulletin of the World Health Organization 90 (3), 209-218, 2012 | 679 | 2012 |
| Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up JD Clemens, DA Sack, JR Harris, F Van Loon, J Chakraborty, F Ahmed, ... The Lancet 335 (8684), 270-273, 1990 | 615 | 1990 |
| A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology L Von Seidlein, DR Kim, M Ali, H Lee, XY Wang, VD Thiem, DG Canh, ... PLoS medicine 3 (9), e353, 2006 | 608 | 2006 |
| Field trial of oral cholera vaccines in Bangladesh JD Clemens, JR Harris, MR Khan, BA Kay, MD Yunus, AM Svennerholm, ... The Lancet 328 (8499), 124-127, 1986 | 601* | 1986 |
| Typhoid fever in children aged less than 5 years A Sinha, S Sazawal, R Kumar, S Sood, VP Reddaiah, B Singh, M Rao, ... The Lancet 354 (9180), 734-737, 1999 | 553 | 1999 |
| Helicobacter in the developing world RW Frenck Jr, J Clemens Microbes and infection 5 (8), 705-713, 2003 | 482 | 2003 |
| Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale … JD Clemens, DA Sack, JR Harris, J Chakraborty, PK Neogy, B Stanton, ... Journal of Infectious Diseases 158 (2), 372-377, 1988 | 396 | 1988 |
| The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study KL Kotloff, WC Blackwelder, D Nasrin, JP Nataro, TH Farag, A Van Eijk, ... Clinical infectious diseases 55 (suppl_4), S232-S245, 2012 | 386 | 2012 |
| Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis M Ali, M Emch, L Von Seidlein, M Yunus, DA Sack, M Rao, J Holmgren, ... The Lancet 366 (9479), 44-49, 2005 | 364 | 2005 |
| A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections ED SHAPIRO, JD CLEMENS Annals of internal medicine 101 (3), 325-330, 1984 | 341 | 1984 |
| Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones TT Chau, JI Campbell, CM Galindo, N Van Minh Hoang, TS Diep, ... Antimicrobial agents and chemotherapy 51 (12), 4315-4323, 2007 | 328 | 2007 |
| Effectiveness of mass oral cholera vaccination in Beira, Mozambique MES Lucas, JL Deen, L Von Seidlein, XY Wang, J Ampuero, M Puri, M Ali, ... New England Journal of Medicine 352 (8), 757-767, 2005 | 323 | 2005 |
| A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness S Ahmed, MM Karim, AG Ross, MS Hossain, JD Clemens, MK Sumiya, ... International Journal of Infectious Diseases 103, 214-216, 2021 | 319 | 2021 |
Holmgren JProfessor University of Gothenburg在 gu.se 的电子邮件经过验证
